Publikationen 2004
1: Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, Irmak S, Kilic
E, Huland H, Friedrich M, Ergun S.
Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in
angiogenesis and invasion of human urinary bladder cancer.
Cancer Res. 2004 Dec 15;64(24):8932-8.
2: Augustin H, Erbersdobler A, Hammerer PG, Graefen M, Huland H.
Prostate cancers in the transition zone: Part 2; clinical aspects.
BJU Int. 2004 Dec;94(9):1226-9. No abstract available.
3: Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD,
Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones
PA, Liang G.
Detection of methylated apoptosis-associated genes in urine sediments of
bladder cancer patients.
Clin Cancer Res. 2004 Nov 15;10(22):7457-65.
4: Panzer U, Reinking RR, Steinmetz OM, Zahner G, Sudbeck U, Fehr S, Pfalzer B,
Schneider A, Thaiss F, Mack M, Conrad S, Huland H, Helmchen U, Stahl RA.
CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft
rejection.
Transplantation. 2004 Nov 15;78(9):1341-50.
5: Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U,
Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a
side-by-side comparison.
Eur Urol. 2004 Oct;46(4):466-71.
6: Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH,
Graefen M, Kattan MW, Huland H, Lilja H.
Association of free-prostate specific antigen subfractions and human glandular
kallikrein 2 with volume of benign and malignant prostatic tissue.
Prostate. 2004 Sep 17;
7: Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland
H, Lokeshwar V.
A side by side comparison of cytology and biomarkers for bladder cancer
detection.
J Urol. 2004 Sep;172(3):1123-6.
8: Huland H, Hautmann R.
8(th) Heinrich-Warner-Foundation-Symposium 30.10-2.11.2003, Hamburg.
Urologe A. 2004 Sep;43 Suppl 3:117. No abstract available.
9: Huland E, Heinzer H, Jorres RA, Loppow D, Huland H.
Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy.
Urologe A. 2004 Sep;43 Suppl 3:140-4.
10: Giessing M, Conrad S, Schonberger B, Huland H, Budde K, Neumayer HH,
Loening SA.
[Kidney donors and kidney transplantation in the elderly]
Urologe A. 2004 Aug;43(8):947-54. German.
11: Huland E, Heinzer H.
Renal cell carcinoma - innovative medical treatments.
Curr Opin Urol. 2004 Jul;14(4):239-44.
12: Haese A, Graefen M, Huland H, Lilja H.
Prostate-specific antigen and related isoforms in the diagnosis and management
of prostate cancer.
Curr Urol Rep. 2004 Jun;5(3):231-40. Review.
13: Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A,
Huland H.
Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with
tumor angiogenesis and prognosis.
Eur Urol. 2004 Jun;45(6):737-43.
14: Haese A, Noldus J, Steuber T, Huland H, Lilja H.
[Isoforms of free prostate-specific antigen]
Urologe A. 2004 Jun;43(6):675-9. Review. German.
15: Toma MI, Friedrich MG, Hautmann SH, Jakel KT, Erbersdobler A, Hellstern A,
Huland H.
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in
the detection and surveillance of bladder cancer.
World J Urol. 2004 Jun;22(2):145-9. Epub 2004 Feb 27.
16: Haese A, Noldus J, Steuber T, Huland H, Lilja H.
[Isoforms of free prostate-specific antigen]
Urologe A. 2004 May 6; [Epub ahead of print] German.
17: Hammerer PG, Augustin H, Blonski J, Graefen M, Haese A, Erbersdobler A,
Daghofer F, Huland H.
[Influence of transrectal endosonography on the clinical staging of impalpable
prostate cancer. A controversy over the TNM system]
Urologe A. 2004 Mar;43(3):307-12.
18: Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F,
Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A,
Schroeder F, Wildhagen M, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL,
Stricker PD, Morash CG, Scardino PT, Kattan MW.
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
J Urol. 2004 Feb;171(2 Pt 1):692-6.
19: Hautmann S, Felix-Chun KH, Currlin E, Friedrich MG, Dose Schwarz J,
Langwieler T, Conrad S, Huland H.
[Cystectomy for indications other than bladder cancer]
Urologe A. 2004 Feb;43(2):172-7. German.
20: Graefen M, Huland H.
[Technique of nerve-sparing radical retropubic prostatectomy]
Urologe A. 2004 Feb;43(2):156-9.
21: Michl UH, Lange D, Graefen M, Huland H.
Re: Intraoperative nerve stimulation with measurement of urethral sphincter
pressure changes during radical retropubic prostatectomy: a feasibility study.
C. P. Nelson, J. E. Montie, E. J. McGuire, G. Wedemeyer and J.T. Wei. J Urol,
169: 2225-2228, 2003.
J Urol. 2004 Jan;171(1):359; author reply 359.
22: Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A,
Erbersdobler A, Henke RP, Huland H, Wheeler TM, Slawin K, Scardino PT, Kattan
MW.
Assessment of the enhancement in predictive accuracy provided by systematic
biopsy in predicting outcome for clinically localized prostate cancer.
J Urol. 2004 Jan;171(1):200-3.
23: Augustin H, Eggert T, Wenske S, Karakiewicz PI, Palisaar J, Daghofer F,
Huland H, Graefen M.
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict
final pathological stage in clinically localized prostate cancer.
J Urol. 2004 Jan;171(1):177-81.
24: Hautmann S, Friedrich MG, Fernandez S, Steuber T, Hammerer P, Braun PM,
Junemann KP, Huland H.
Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal
of small distal ureteral stones.
Urol Int. 2004;73(3):238-43.
© Universitätsklinikum Hamburg-Eppendorf,
ImpressumLetzte Änderung:
, 25.01.2005
